Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GRAL

GRAIL Inc

Nov 17 • 04:00PM ET

84.94

+5.31 6.67 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN EXAS GH PACB TXG QGEN CRSP EDIT CDNA FULC

| Held by: VTI IWM XBI VXF IWN IBB VTWO SCHA VHT PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-11.61	Insider Own	16.78%	Shs Outstand	36.16M	Perf Week	-0.20%
Market Cap	3.31B	Forward P/E	-	EPS next Y	-11.09	Insider Trans	-6.91%	Shs Float	32.44M	Perf Month	8.90%
Enterprise Value	2.83B	PEG	-	EPS next Q	-3.05	Inst Own	65.66%	Short Float	16.70%	Perf Quarter	170.34%
Income	-406.24M	P/S	23.35	EPS this Y	83.28%	Inst Trans	-6.35%	Short Ratio	5.54	Perf Half Y	122.18%
Sales	141.83M	P/B	1.37	EPS next Y	-4.38%	ROA	-14.21%	Short Interest	5.42M	Perf YTD	375.85%
Book/sh	61.94	P/C	6.13	EPS next 5Y	44.18%	ROE	-16.83%	52W High	103.00 -17.53%	Perf Year	433.54%
Cash/sh	13.86	P/FCF	-	EPS past 3/5Y	-14.17% -89.93%	ROIC	-17.78%	52W Low	13.58 525.48%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	104.84% -	Gross Margin	-55.85%	Volatility	11.61% 10.04%	Perf 5Y	-
Dividend TTM	-	EV/Sales	19.95	EPS Y/Y TTM	82.91%	Oper. Margin	-385.98%	ATR (14)	8.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.37	Sales Y/Y TTM	20.53%	Profit Margin	-286.43%	RSI (14)	55.80	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.61	EPS Q/Q	34.93%	SMA20	0.47%	Beta	4.64	Target Price	96.67
Payout	-	Debt/Eq	0.03	Sales Q/Q	26.32%	SMA50	25.26%	Rel Volume	1.29	Prev Close	79.63
Employees	1000	LT Debt/Eq	0.02	Earnings	Nov 12 AMC	SMA200	93.12%	Avg Volume	976.97K	Price	84.94
IPO	Jun 12, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	26.89% 4.61%	Trades		Volume	1,257,220	Change	6.67%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-12-25	Upgrade	Guggenheim	Neutral → Buy	$100
Apr-21-25	Initiated	Canaccord Genuity	Buy	$32
Nov-27-24	Initiated	Morgan Stanley	Equal-Weight	$16
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Oct-17-24	Initiated	Guggenheim	Neutral

Nov-17-25 07:30PM	Why Grail Stock Zoomed Nearly 7% Higher on Monday (Motley Fool) +6.67%
Nov-13-25 12:03AM	GRAIL Inc (GRAL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-12-25 04:02PM	GRAIL Reports Third Quarter 2025 Financial Results (PR Newswire)
09:06AM	Here Are Wednesdays Top Wall Street Analyst Research Calls: AT&T, Beyond Meat, Carvana, Fortinet, Snowflake, Waste Managment and More (24/7 Wall St.)
05:25AM	Cisco Systems headlines earnings slate (MarketWatch)
03:51AM	Loading…
03:51AM	Stock Market Today: Dow consolidates after 3-day 1,000-point surge to record high, S&P 500 and Nasdaq called higher as Treasury yields dip; Cisco earnings on tap. (MarketWatch)
Nov-06-25 06:00AM	Here's Why Grail Stock Exploded Higher by 55% in October (Motley Fool) -5.41%
Nov-04-25 04:02PM	GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference (PR Newswire) -10.15%
Oct-29-25 04:02PM	GRAIL to Announce Third Quarter 2025 Financial Results (PR Newswire) +6.97%
Oct-25-25 12:45AM	Jim Cramer on GRAIL: "Don't Call Yourself Early if You're Buying This One" (Insider Monkey)
Oct-24-25 08:12AM	Jim Cramer on GRAIL: "I'm Going to Say Absolutely Not to That One" (Insider Monkey) +8.15%
Oct-23-25 09:55AM	Grail Stock Is Up 80% Over the Past Month. Here's Why. (Motley Fool)
Oct-22-25 08:12PM	GRAIL, Inc. (GRAL): A Bull Case Theory (Insider Monkey)
Oct-20-25 04:21PM	Stock Of The Day: Why IBD 50's Guardant Health Has Rallied 31% In A Month (Investor's Business Daily) +17.76% -8.86%
06:30AM	GRAIL, Inc. Announces $325.0 Million Private Placement Financing (PR Newswire)
06:00AM	Loading…
06:00AM	GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC) (PR Newswire)
Oct-18-25 04:16AM	Grail Blood Test Found Seven Times More Cancers Than Standard Tests, Data Show (Barrons.com)
Oct-17-25 06:08PM	GRAIL PATHFINDER 2 Results Show Galleri Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings (PR Newswire) -9.73% +17.76%
09:00AM	Precision Oncology Approaches Drive $312B Market Transformation (PR Newswire)
04:21AM	Samsung entities, Grail to roll out early cancer detection test in Asia (Medical Device Network)
Oct-16-25 06:52PM	Why Grail Stock Soared 14% Higher on Thursday (Motley Fool) +14.42%
08:22AM	Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri Multi-Cancer Early Detection Test to Asia (PR Newswire)
Sep-26-25 12:46PM	This Cancer Detection Pioneer Is Worth a Look (Motley Fool)
11:25AM	Guardants New Blood Test Can Detect Many Different Cancers. The Company Is Promising the Same for Other Diseases. (Barrons.com)
Sep-25-25 02:24PM	Guardant's New Blood Test Can Detect Many Different Cancers. It's Promising the Same for Other Diseases. (Barrons.com)
Sep-23-25 09:01AM	GRAIL to Present New Galleri Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC (PR Newswire) +5.62%
Sep-20-25 09:39AM	GRAIL Gains Momentum Post-IPO Amid Strong Sales, Partnerships, and Executive Share Activity (Insider Monkey)
Sep-16-25 12:12PM	GRAIL, Inc. (GRAL): A Bull Case Theory (Insider Monkey)
Sep-11-25 05:33PM	More Blood Tests for Cancer Hit the Market (Barrons.com) +9.12%
Sep-10-25 04:02PM	GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum (PR Newswire) -5.62%
04:01PM	Loading…
Aug-29-25 04:01PM	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Aug-26-25 04:02PM	GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference (PR Newswire)
Aug-13-25 03:14AM	GRAIL Inc (GRAL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Aug-12-25 04:02PM	GRAIL Reports Second Quarter 2025 Financial Results (PR Newswire)
Aug-11-25 06:55PM	BioHarvest Sciences Inc. (BHST) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
09:06AM	Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024 (GlobeNewswire)
Aug-08-25 05:15PM	Femasys Inc. (FEMY) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-07-25 07:35PM	Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Jul-30-25 04:02PM	GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference (PR Newswire)
Jul-29-25 04:02PM	GRAIL to Announce Second Quarter 2025 Financial Results (PR Newswire) -10.84%
Jul-14-25 11:11AM	GRAIL's Galleri Multi-Cancer Test Shows Strong Performance in PATHFINDER 2 Study, Paves Way for FDA Submission (Insider Monkey)
Jul-09-25 07:34AM	Grail (GRAL) PT Hiked to $38 at Morgan Stanley amid 'Equal Weight' Stance (Insider Monkey)
Jun-30-25 04:22PM	Stock Market Today: Dow Jones Up As Apple, Palantir Surge; Robinhood Soars To New Highs On These Moves (Investor's Business Daily) +6.26%
Jun-23-25 12:51PM	Stock Market Today: Dow Jones Reverses, Tesla Surges; These Defense Stocks Gain After Iran Attack (Live Coverage) (Investor's Business Daily) -5.61%
Jun-20-25 09:21AM	With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology (PR Newswire) -5.80%
Jun-19-25 07:05AM	Grail reports positive outcomes from registrational study of Galleri test (Medical Device Network)
Jun-18-25 09:01AM	GRAIL Announces Positive Top-Line Results From The Galleri PATHFINDER 2 Registrational Study (PR Newswire) +15.20%
Jun-09-25 07:29AM	3 Medical Technology Stocks Outperforming in 2025 (MarketBeat)
May-30-25 04:05PM	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) -6.55%
May-23-25 09:47AM	Stock Market News for May 23, 2025 (Zacks)
May-21-25 04:05PM	GRAIL to Present at Jefferies Global Healthcare Conference 2025 (PR Newswire)
May-14-25 07:11AM	Q1 2025 Grail Inc Earnings Call (Thomson Reuters StreetEvents) -23.32%
06:56AM	Grail partners with athenahealth for MCED test ordering (Medical Device Network)
03:18AM	GRAIL Inc (GRAL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances (GuruFocus.com)
May-13-25 04:01PM	GRAIL Reports First Quarter 2025 Financial Results (PR Newswire) +19.17%
May-12-25 04:01PM	GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri Multi-Cancer Early Detection (MCED) Test (PR Newswire)
May-02-25 12:52PM	Exact Sciences Q1 Earnings: Decent Quarter, But Growth Story Not Compelling (Seeking Alpha) +10.11%
Apr-30-25 05:43AM	Why GRAIL, Inc. (GRAL) is Surging in 2025 (Insider Monkey) -6.28%
Apr-29-25 04:01PM	GRAIL to Announce First Quarter 2025 Financial Results (PR Newswire)
Apr-22-25 04:01PM	GRAIL to Present New Data on Galleri and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting (PR Newswire) +12.38% +13.71%
Apr-21-25 04:47PM	This Cancer Test Could Become Routineand a Big Seller, Says Analyst (Barrons.com)
Apr-16-25 03:02PM	GRAIL, Inc. (GRAL): A Bull Case Theory (Insider Monkey)
Apr-12-25 09:32AM	GRAIL's Galleri Progresses While Back In Accumulation Levels (Seeking Alpha)
Apr-08-25 09:49AM	How Does GRAIL Benefit From The Proposed MCED Legislation? (Seeking Alpha) -10.78%
Mar-31-25 11:36AM	Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses - Great Science, Risky Bet! (Insider Monkey) -5.16%
Mar-03-25 12:30PM	Is GRAIL, Inc. (GRAL) Among Jeff Bezos Investments in 2025? (Insider Monkey) -5.78%
Feb-26-25 04:05PM	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) -10.45%
Feb-25-25 09:00AM	GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing (PR Newswire)
Feb-24-25 02:02PM	GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025 (Insider Monkey) +11.22%
Feb-21-25 10:00AM	Why Grail (GRAL) Is Falling Today (Insider Monkey) -14.72%
09:00AM	GRAIL to Present at TD Cowen 45th Annual Health Care Conference (PR Newswire)
02:15AM	GRAIL Inc (GRAL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
Feb-20-25 04:02PM	GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire) -9.20%
Feb-19-25 10:10AM	Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire) +11.61%
Feb-12-25 04:02PM	GRAIL to Announce Fourth Quarter 2024 Financial Results (PR Newswire) +18.43% +33.93%
12:50PM	Why Grail (GRAL) Stock Is Jumping Today (Insider Monkey)
09:00AM	GRAIL and Quest Diagnostics Provide GRAIL's Galleri Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System (PR Newswire)
Jan-26-25 11:12PM	Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week (Investopedia)
Jan-23-25 12:42PM	Why Grail (GRAL) Is Rallying for a Second Straight Day (Insider Monkey) +14.71%
Jan-22-25 12:21PM	Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20% (Investopedia) +22.44%
Jan-21-25 10:48AM	Stock Market Today: Dow Jones Up After These Trump Moves; Cathie Wood Loads Up On AI Stock (Live Coverage) (Investor's Business Daily) +6.14%
Jan-13-25 06:49PM	Patient Reported Outcomes for GRAIL's Galleri Multi-Cancer Early Detection Blood Test Published in Lancet Oncology (PR Newswire)
Dec-18-24 04:01PM	GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire) -23.41% -5.25%
Dec-16-24 01:43PM	What's Going On With Illumina Stock On Monday? (Benzinga)
Dec-10-24 02:52PM	One Of IBD's Best Screens Identifies These Four Market Leaders, Including Garmin, Ollie's (Investor's Business Daily) -6.03%
Dec-05-24 01:40PM	Stock Market Today: Dow Jones Keeps Losses Tidy As New Medical IPO Breaks Out (Live Coverage) (Investor's Business Daily) +10.78%
Dec-03-24 04:01PM	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-19-24 04:05PM	GRAIL to Participate in Upcoming Investor Conferences (PR Newswire) +5.64%
Nov-18-24 04:01PM	GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study (PR Newswire) -5.41%
09:16AM	Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now? (Insider Monkey)
Nov-14-24 02:00PM	GRAIL Inc (GRAL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... (GuruFocus.com)
Nov-12-24 04:06PM	GRAIL Reports Third Quarter 2024 Financial Results (PR Newswire) +5.50%
Nov-04-24 04:01PM	GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (PR Newswire)
Oct-29-24 04:01PM	GRAIL to Announce Third Quarter 2024 Financial Results (PR Newswire)
Oct-23-24 06:00PM	GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference (PR Newswire) -5.12%
Oct-21-24 04:01PM	GRAIL Appoints Sarah Krevans to Board of Directors (PR Newswire)
Oct-16-24 02:00AM	Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer (GlobeNewswire)
Oct-13-24 04:59PM	GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now (Insider Monkey)
Sep-30-24 09:04PM	CRCM LP's Strategic Acquisition of GRAIL Inc Shares (GuruFocus.com)
Sep-03-24 11:37AM	Illumina Wins Court Fight With EU Over $7 Billion Grail Deal (Bloomberg) -6.02%

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Aaron Freidin	Officer	Nov 17 '25	Proposed Sale	79.63	1,940	154,482		Nov 14 06:15 PM
RAGUSA ROBERT P	Chief Executive Officer	Oct 15 '25	Sale	68.88	7,239	498,622	727,388	Oct 16 06:18 PM
Ofman Joshua J.	President	Oct 15 '25	Sale	76.03	8,865	673,985	387,932	Oct 16 06:17 PM
Ofman Joshua J.	President	Oct 16 '25	Sale	82.01	6,114	501,409	381,818	Oct 16 06:17 PM
JOSHUA J OFMAN	Officer	Oct 15 '25	Proposed Sale	69.29	14,979	1,037,895		Oct 15 04:36 PM
Robert Ragusa	Officer	Oct 15 '25	Proposed Sale	69.29	8,275	573,375		Oct 14 06:09 PM
Ofman Joshua J.	President	Oct 06 '25	Sale	62.50	81,385	5,086,562	396,797	Oct 08 04:14 PM
Ofman Joshua J.	President	Oct 02 '25	Sale	64.00	9,692	620,312	478,182	Oct 03 07:01 PM
Joshua Ofman	Officer	Oct 06 '25	Proposed Sale	65.54	89,237	5,848,593		Oct 03 06:56 PM
JOSHUA J OFMAN	Officer	Oct 02 '25	Proposed Sale	62.06	9,692	601,486		Oct 02 04:23 PM
Ofman Joshua J.	President	Aug 19 '25	Sale	32.02	4,202	134,548	487,874	Aug 20 04:24 PM
Freidin Aaron	Chief Financial Officer	Aug 19 '25	Sale	32.02	877	28,082	285,143	Aug 20 04:23 PM
Joshua J. Ofman	Officer	Aug 21 '25	Proposed Sale	32.80	4,511	147,964		Aug 18 08:34 PM
Aaron Freidin	Officer	Aug 21 '25	Proposed Sale	32.43	952	30,873		Aug 15 09:07 PM
Freidin Aaron	Chief Financial Officer	Jul 15 '25	Sale	38.93	8,000	311,440	286,020	Jul 17 05:44 PM
AARON FREIDIN	Officer	Jul 15 '25	Proposed Sale	40.18	8,000	321,440		Jul 15 04:43 PM
DING CHUN R	10% Owner	Jul 01 '25	Sale	49.53	339,800	16,830,151	3,305,055	Jul 03 04:31 PM
Ofman Joshua J.	President	Jun 30 '25	Sale	52.00	9,692	503,984	492,076	Jul 01 04:11 PM
JOSHUA J OFMAN	Officer	Jun 30 '25	Proposed Sale	48.39	9,692	468,996		Jun 30 04:21 PM
Ofman Joshua J.	President	Jun 12 '25	Sale	42.30	9,692	410,019	501,768	Jun 16 04:08 PM
JOSHUA J OFMAN	Officer	Jun 12 '25	Proposed Sale	43.87	9,692	425,188		Jun 12 04:19 PM
Ofman Joshua J.	President	May 02 '25	Sale	33.93	48,213	1,635,867	511,460	May 05 09:44 PM
Freidin Aaron	Chief Financial Officer	May 02 '25	Sale	33.93	41,150	1,396,220	294,020	May 05 08:46 PM
RAGUSA ROBERT P	Chief Executive Officer	May 02 '25	Sale	33.93	94,035	3,190,608	734,627	May 05 08:44 PM
Aaron Freidin	Officer	May 01 '25	Proposed Sale	36.81	42,138	1,551,100		Apr 29 09:06 PM
Robert Ragusa	Director	May 01 '25	Proposed Sale	36.81	96,207	3,541,380		Apr 29 08:29 PM
Joshua J. Ofman	Officer	May 01 '25	Proposed Sale	36.81	47,083	1,733,136		Apr 29 08:19 PM
RAGUSA ROBERT P	Chief Executive Officer	Mar 07 '25	Sale	31.21	7,625	237,976	828,662	Mar 12 04:07 PM
Ofman Joshua J.	President	Mar 07 '25	Sale	31.20	2,109	65,801	559,673	Mar 12 04:06 PM
Freidin Aaron	Chief Financial Officer	Mar 07 '25	Sale	31.20	1,816	56,659	335,170	Mar 12 04:04 PM
Robert Ragusa	Officer	Mar 05 '25	Proposed Sale	36.33	9,102	330,676		Mar 03 08:40 PM
Joshua J. Ofman	Officer	Mar 05 '25	Proposed Sale	36.33	2,897	105,248		Mar 03 08:02 PM
Aaron Freidin	Officer	Mar 05 '25	Proposed Sale	36.33	2,560	93,005		Mar 03 08:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GRAL

GRAIL Inc

Upgrade your FINVIZ experience